Analyst Ratings for Kyverna Therapeutics Inc (KYTX)
KYTX Rating Summary
KYTX Price Target Summary
- Highest: $33.00 (Morgan Stanley)
- Lowest: $25.00 (H.C. Wainwright)
- Average: $30.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$30.00 (+271.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$30.00 (+271.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2025 | William Blair » Updated 4/22/2026 |
Sami Corwin | New Coverage | Outperform (N/A) |
N/A (N/A) |
3.30 (8.07) |
144.55% | Details |
| 5/27/2025 | H.C. Wainwright » Updated 6/4/2026 |
Mitchell S. Kapoor | Upgrade | Buy (Neutral) |
25.00 (N/A) |
2.27 (8.07) |
255.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
